ARCOSA INC (ACA) Fundamental Analysis & Valuation

NYSE:ACA • US0396531008

Current stock price

104.26 USD
+3.58 (+3.56%)
At close:
104.26 USD
0 (0%)
After Hours:

This ACA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. ACA Profitability Analysis

1.1 Basic Checks

  • In the past year ACA was profitable.
  • ACA had a positive operating cash flow in the past year.
  • Each year in the past 5 years ACA has been profitable.
  • Each year in the past 5 years ACA had a positive operating cash flow.
ACA Yearly Net Income VS EBIT VS OCF VS FCFACA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

1.2 Ratios

  • The Return On Assets of ACA (4.17%) is comparable to the rest of the industry.
  • ACA has a Return On Equity (7.88%) which is comparable to the rest of the industry.
  • Looking at the Return On Invested Capital, with a value of 5.80%, ACA is in line with its industry, outperforming 44.64% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for ACA is significantly below the industry average of 17.25%.
  • The 3 year average ROIC (4.62%) for ACA is below the current ROIC(5.80%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.17%
ROE 7.88%
ROIC 5.8%
ROA(3y)3.51%
ROA(5y)4%
ROE(3y)6.18%
ROE(5y)6.66%
ROIC(3y)4.62%
ROIC(5y)4.24%
ACA Yearly ROA, ROE, ROICACA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • ACA has a Profit Margin of 7.22%. This is in the better half of the industry: ACA outperforms 71.43% of its industry peers.
  • ACA's Profit Margin has improved in the last couple of years.
  • The Operating Margin of ACA (11.37%) is better than 75.00% of its industry peers.
  • ACA's Operating Margin has improved in the last couple of years.
  • Looking at the Gross Margin, with a value of 22.45%, ACA is in the better half of the industry, outperforming 69.64% of the companies in the same industry.
  • ACA's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 11.37%
PM (TTM) 7.22%
GM 22.45%
OM growth 3Y16.52%
OM growth 5Y6.57%
PM growth 3Y-12.89%
PM growth 5Y5.71%
GM growth 3Y5.99%
GM growth 5Y2.61%
ACA Yearly Profit, Operating, Gross MarginsACA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. ACA Health Analysis

2.1 Basic Checks

  • ACA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • ACA has more shares outstanding than it did 1 year ago.
  • ACA has more shares outstanding than it did 5 years ago.
  • ACA has a better debt/assets ratio than last year.
ACA Yearly Shares OutstandingACA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
ACA Yearly Total Debt VS Total AssetsACA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

2.2 Solvency

  • An Altman-Z score of 2.52 indicates that ACA is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.52, ACA is in line with its industry, outperforming 44.64% of the companies in the same industry.
  • The Debt to FCF ratio of ACA is 8.68, which is on the high side as it means it would take ACA, 8.68 years of fcf income to pay off all of its debts.
  • ACA has a Debt to FCF ratio of 8.68. This is comparable to the rest of the industry: ACA outperforms 55.36% of its industry peers.
  • A Debt/Equity ratio of 0.57 indicates that ACA is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.57, ACA is in line with its industry, outperforming 57.14% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 8.68
Altman-Z 2.52
ROIC/WACC0.58
WACC9.91%
ACA Yearly LT Debt VS Equity VS FCFACA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

  • ACA has a Current Ratio of 2.20. This indicates that ACA is financially healthy and has no problem in meeting its short term obligations.
  • With an excellent Current ratio value of 2.20, ACA belongs to the best of the industry, outperforming 89.29% of the companies in the same industry.
  • ACA has a Quick Ratio of 1.35. This is a normal value and indicates that ACA is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of ACA (1.35) is better than 67.86% of its industry peers.
Industry RankSector Rank
Current Ratio 2.2
Quick Ratio 1.35
ACA Yearly Current Assets VS Current LiabilitesACA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. ACA Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 48.50% over the past year.
  • The Earnings Per Share has been growing by 12.78% on average over the past years. This is quite good.
  • ACA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 12.20%.
  • The Revenue has been growing by 8.30% on average over the past years. This is quite good.
EPS 1Y (TTM)48.5%
EPS 3Y26.66%
EPS 5Y12.78%
EPS Q2Q%150%
Revenue 1Y (TTM)12.2%
Revenue growth 3Y8.74%
Revenue growth 5Y8.3%
Sales Q2Q%7.58%

3.2 Future

  • The Earnings Per Share is expected to grow by 11.17% on average over the next years. This is quite good.
  • Based on estimates for the next years, ACA will show a small growth in Revenue. The Revenue will grow by 5.28% on average per year.
EPS Next Y9.06%
EPS Next 2Y11.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.88%
Revenue Next 2Y5.28%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ACA Yearly Revenue VS EstimatesACA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
ACA Yearly EPS VS EstimatesACA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

More info and screens

Find the best growth stocksShow best growing peers

4

4. ACA Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 23.32 indicates a rather expensive valuation of ACA.
  • Based on the Price/Earnings ratio, ACA is valued a bit cheaper than 78.57% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.54. ACA is around the same levels.
  • A Price/Forward Earnings ratio of 21.39 indicates a rather expensive valuation of ACA.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ACA indicates a somewhat cheap valuation: ACA is cheaper than 76.79% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.70, ACA is valued at the same level.
Industry RankSector Rank
PE 23.32
Fwd PE 21.39
ACA Price Earnings VS Forward Price EarningsACA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • ACA's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. ACA is cheaper than 82.14% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, ACA is valued a bit cheaper than 64.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 29.13
EV/EBITDA 11.66
ACA Per share dataACA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ACA does not grow enough to justify the current Price/Earnings ratio.
  • The decent profitability rating of ACA may justify a higher PE ratio.
PEG (NY)2.57
PEG (5Y)1.83
EPS Next 2Y11.17%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. ACA Dividend Analysis

5.1 Amount

  • ACA has a yearly dividend return of 0.20%, which is pretty low.
  • Compared to an average industry Dividend Yield of 0.14, ACA pays a better dividend. On top of this ACA pays more dividend than 82.14% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, ACA's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.2%

5.2 History

  • The dividend of ACA has a limited annual growth rate of 0.14%.
  • ACA has been paying a dividend for over 5 years, so it has already some track record.
  • As ACA did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)0.14%
Div Incr Years0
Div Non Decr Years5
ACA Yearly Dividends per shareACA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 2026 0.05 0.1 0.15

5.3 Sustainability

  • ACA pays out 4.81% of its income as dividend. This is a sustainable payout ratio.
  • ACA's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP4.81%
EPS Next 2Y11.17%
EPS Next 3YN/A
ACA Yearly Income VS Free CF VS DividendACA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M
ACA Dividend Payout.ACA Dividend Payout, showing the Payout Ratio.ACA Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ACA Fundamentals: All Metrics, Ratios and Statistics

ARCOSA INC

NYSE:ACA (3/23/2026, 8:04:00 PM)

After market: 104.26 0 (0%)

104.26

+3.58 (+3.56%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)02-26
Earnings (Next)05-04
Inst Owners94.27%
Inst Owner Change-3.24%
Ins Owners1.85%
Ins Owner Change8.12%
Market Cap5.11B
Revenue(TTM)2.88B
Net Income(TTM)208.10M
Analysts84.44
Price Target125.66 (20.53%)
Short Float %1.88%
Short Ratio3.15
Dividend
Industry RankSector Rank
Dividend Yield 0.2%
Yearly Dividend0.2
Dividend Growth(5Y)0.14%
DP4.81%
Div Incr Years0
Div Non Decr Years5
Ex-Date04-15
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)19.92%
Min EPS beat(2)15.61%
Max EPS beat(2)24.24%
EPS beat(4)4
Avg EPS beat(4)54.93%
Min EPS beat(4)15.61%
Max EPS beat(4)162.24%
EPS beat(8)7
Avg EPS beat(8)28.84%
EPS beat(12)11
Avg EPS beat(12)33.04%
EPS beat(16)15
Avg EPS beat(16)36.75%
Revenue beat(2)1
Avg Revenue beat(2)-0.02%
Min Revenue beat(2)-1.23%
Max Revenue beat(2)1.18%
Revenue beat(4)2
Avg Revenue beat(4)-0.48%
Min Revenue beat(4)-3.72%
Max Revenue beat(4)1.83%
Revenue beat(8)3
Avg Revenue beat(8)-1.48%
Revenue beat(12)6
Avg Revenue beat(12)0.12%
Revenue beat(16)10
Avg Revenue beat(16)1.69%
PT rev (1m)-0.48%
PT rev (3m)2.81%
EPS NQ rev (1m)-18.87%
EPS NQ rev (3m)-18.49%
EPS NY rev (1m)1.08%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-3.79%
Revenue NQ rev (3m)-3.75%
Revenue NY rev (1m)-1.4%
Revenue NY rev (3m)-1.94%
Valuation
Industry RankSector Rank
PE 23.32
Fwd PE 21.39
P/S 1.77
P/FCF 29.13
P/OCF 14.99
P/B 1.94
P/tB 5.21
EV/EBITDA 11.66
EPS(TTM)4.47
EY4.29%
EPS(NY)4.88
Fwd EY4.68%
FCF(TTM)3.58
FCFY3.43%
OCF(TTM)6.96
OCFY6.67%
SpS58.8
BVpS53.86
TBVpS20.02
PEG (NY)2.57
PEG (5Y)1.83
Graham Number73.6
Profitability
Industry RankSector Rank
ROA 4.17%
ROE 7.88%
ROCE 7.32%
ROIC 5.8%
ROICexc 6.09%
ROICexgc 9.96%
OM 11.37%
PM (TTM) 7.22%
GM 22.45%
FCFM 6.09%
ROA(3y)3.51%
ROA(5y)4%
ROE(3y)6.18%
ROE(5y)6.66%
ROIC(3y)4.62%
ROIC(5y)4.24%
ROICexc(3y)4.82%
ROICexc(5y)4.43%
ROICexgc(3y)8.06%
ROICexgc(5y)7.51%
ROCE(3y)5.83%
ROCE(5y)5.36%
ROICexgc growth 3Y7.62%
ROICexgc growth 5Y-0.63%
ROICexc growth 3Y10.26%
ROICexc growth 5Y1.46%
OM growth 3Y16.52%
OM growth 5Y6.57%
PM growth 3Y-12.89%
PM growth 5Y5.71%
GM growth 3Y5.99%
GM growth 5Y2.61%
F-Score9
Asset Turnover0.58
Health
Industry RankSector Rank
Debt/Equity 0.57
Debt/FCF 8.68
Debt/EBITDA 2.75
Cap/Depr 74.26%
Cap/Sales 5.74%
Interest Coverage 3.18
Cash Conversion 61.92%
Profit Quality 84.33%
Current Ratio 2.2
Quick Ratio 1.35
Altman-Z 2.52
F-Score9
WACC9.91%
ROIC/WACC0.58
Cap/Depr(3y)99.71%
Cap/Depr(5y)89.53%
Cap/Sales(3y)7.31%
Cap/Sales(5y)6.45%
Profit Quality(3y)151.62%
Profit Quality(5y)117.46%
High Growth Momentum
Growth
EPS 1Y (TTM)48.5%
EPS 3Y26.66%
EPS 5Y12.78%
EPS Q2Q%150%
EPS Next Y9.06%
EPS Next 2Y11.17%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)12.2%
Revenue growth 3Y8.74%
Revenue growth 5Y8.3%
Sales Q2Q%7.58%
Revenue Next Year3.88%
Revenue Next 2Y5.28%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y67.98%
EBIT growth 3Y26.7%
EBIT growth 5Y15.41%
EBIT Next Year75.5%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-43.8%
FCF growth 3Y69.09%
FCF growth 5Y-0.26%
OCF growth 1Y-32.05%
OCF growth 3Y25.08%
OCF growth 5Y5.59%

ARCOSA INC / ACA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ARCOSA INC?

ChartMill assigns a fundamental rating of 6 / 10 to ACA.


Can you provide the valuation status for ARCOSA INC?

ChartMill assigns a valuation rating of 4 / 10 to ARCOSA INC (ACA). This can be considered as Fairly Valued.


How profitable is ARCOSA INC (ACA) stock?

ARCOSA INC (ACA) has a profitability rating of 7 / 10.


What is the valuation of ARCOSA INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ARCOSA INC (ACA) is 23.32 and the Price/Book (PB) ratio is 1.94.


How financially healthy is ARCOSA INC?

The financial health rating of ARCOSA INC (ACA) is 5 / 10.